Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
339 Immune profiling to investigate improved survival in patients with metastatic triple-negative breast cancer receiving trilaciclib prior to chemotherapy
Compose a Response to This Article
Other responses
No responses have been published for this article.